The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

Endocrine Connections

Maria Papageorgiou¹  Alan S Rigby²  Leigh A Madden³  Zeeshan Javed³  Thozhukat Sathyapalan⁴  Stephen L Atkin⁵  Eric S Kilpatrick⁶ 

[1] Department of Endocrinology and Diabetes, Pakistan Kidney and Liver Institute and Research Centre, Knowledge City, Lahore, Pakistan;Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland;Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, UK;Department of Pathology, Sidra Medical and Research Center, Doha, Qatar;Hull York Medical School, University of Hull, Hull, UK;School of Life Sciences, University of Hull, Hull, UK;

关键词: endothelial microparticles;    polycystic ovary syndrome;    sglt2 inhibitors;    empagliflozin;    metformin;   

DOI  :  https://doi.org/10.1530/EC-20-0173

来源: DOAJ

【 授权许可】

Unknown